TIL · Instil Bio, Inc. · Webcasts, Transcripts & Audio
$5.77
-0.17 (-2.86%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing states the doubt was alleviated.
“As discussed above and in Note 10 to the accompanying condensed consolidated financial statements, the 2024 Loan is due in January 2027, for total principal of $85.6 million, which is in excess of cash, cash equivalents, and marketable securities on hand as of June 30, 2026, which we concluded is an indicator of substantial doubt about our ability to continue as a going concern. We concluded that management's plans, including Complex Therapeutics LLC's contractual right to exercise the extension option to January 2028, which is within Complex Therapeutics LLC's control, alleviate the conditions that raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$40.69M
Shares
6.78M
Volume · Oct 21
40.87K
Avg daily vol (3M)
17.94K
Instil Bio, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Instil Bio, Inc. (TIL), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
No Webcasts Available
No webcast events are available for this stock yet.